Magnetar Financial’s Antares Pharma, Inc. ATRS Stock Holding History

Magnetar Financial’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-375,546	Closed	-$1.54M	–	1998
2022 Q1	$1.54M	Sell	375,546 -1,379,754	-79%	-$5.01M	0.02%	721
2021 Q4	$6.27M	Buy	1,755,300 +882,324	+101%	+$3.09M	0.06%	309
2021 Q3	$3.18M	Buy	872,976 +548,754	+169%	+$2.22M	0.03%	509
2021 Q2	$1.41K	Buy	324,222 +138,327	+74%	+$564K	0.01%	649
2021 Q1	$764K	Sell	185,895 -2,682	-1%	-$11.6K	0.01%	741
2020 Q4	$752K	Buy	188,577 +6,471	+4%	+$20.9K	0.01%	517
2020 Q3	$492K	Buy	182,106 +85,882	+89%	+$238K	0.01%	449
2020 Q2	$265K	Buy	96,224 +17,644	+22%	+$49.2K	0.01%	352
2020 Q1	$185K	Buy	+78,580	New	+$267K	﹤0.01%	406

Other funds holding ATRS

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Magnetar Financial's ATRS Position: Q2 2022 in Review

Magnetar Financial sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 375,546 shares — an estimated $1.54M sold.

Magnetar Financial first reported a position in ATRS in Q1 2020 and held it in 9 quarters. The position peaked at $6.27M in Q4 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Magnetar Financial reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Magnetar Financial sold 375,546 Antares Pharma, Inc. shares in Q2 2022, an estimated $1.54M.
Magnetar Financial first reported a position in Antares Pharma, Inc. in Q1 2020 and held it in 9 quarters.
Magnetar Financial's Antares Pharma, Inc. position peaked at $6.27M in Q4 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Magnetar Financial's 13F filing for Q2 2022, filed 15 Aug 2022.